SEARCH

SEARCH BY CITATION

References

  • Arendash G. W., Garcia M. F., Costa D. A., Cracchiolo J. R., Wefes I. M. and Potter H. (2004) Environmental enrichment improves cognition in aged Alzheimer’s transgenic mice despite stable beta-amyloid deposition. Neuroreport 15, 17511754.
  • Backstrom J. R., Lim G. P., Cullen M. J. and Tokes Z. A. (1996) Matrix metalloproteinase −9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-beta peptide (1-40). J. Neurosci. 16, 79107919.
  • Bazan N. G., Palacios-Pelaez R. and Lukiw W. J. (2002) Hypoxia signaling to genes: significance in Alzheimer’s disease. Mol. Neurobiol. 26, 283298.
  • Benzing W. C., Wujek J. R., Ward E. K., Shaffer D., Ashe K. H., Younkin S. G. and Brunden K. R. (1999) Evidence for glial-mediated inflammation in aged APPsw transgenic mice. Neurobiol. Aging 20, 581589.
  • Catania C., Sotiropoulos I., Silva R., Onofri C., Breen K. C., Sousa N. and Almeida O. F. (2007) The amyloidogenic potential and behavioral correlates of stress. Mol. Psychiatry. 2, 111.
  • Cook S. C. and Wellman C. L. (2004) Chronic stress alters dendritic morphology in rat medial prefrontal cortex. J. Neurobiol. 60, 236248.
  • Csernansky J. G., Dong H., Fagan A. M., Wang L., Xiong C., Holtzman D. M. and Morris J. C. (2006) Plasma cortisol and progression of dementia in subjects with Alzheimer-type dementia. Am. J. Psychiatry 163, 21642169.
  • Dong H., Goico B., Martin M., Csernansky C. A., Bertchume A. and Csernansky J. G. (2004) Modulation of hippocampal cell proliferation, memory, and amyloid plaque deposition in APPsw (Tg2576) mutant mice by isolation stress. Neuroscience 127, 601609.
  • Frank B. and Gupta S. (2005) A review of antioxidants and Alzheimer’s disease. Ann. Clin. Psychiatry 17, 269286.
  • Goedert M. and Spillantini M. G. (2006) A century of Alzheimer’s disease. Science 314, 777781.
  • Grant W. B., Campbell A., Itzhaki R. F. and Savory J. (2002) The significance of environmental factors in the etiology of Alzheimer’s disease. J. Alzheimers. Dis. 4, 179189.
  • Green K. N., Billings L. M., Roozendaal B., McGaugh J. L. and LaFerla F. M. (2006) Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimer’s disease. J. Neurosci. 26, 90479056.
  • Harman D. (2006) Alzheimer’s disease pathogenesis: role of aging. Ann. N.Y. Acad. Sci. 1067, 454460.
  • Harris R. B., Mitchell T. D., Simpson J., Redmann S. M. Jr, Youngblood B. D. and Ryan D. H. (2002) Weight loss in rats exposed to repeated acute restraint stress is independent of energy or leptin status. Am. J. Physiol. Regul. Integr. Comp. Physiol. 282, 7788.
  • Hof P. and Morrison J. H. (1999) The cellular basis of cortical disconnection in Alzheimer disease and related dementing conditions, in Alzheimer Disease, 2nd edn (TerryR. D., KatzmanR., BickK. L. and SisodiaS. S., eds), pp. 207232. Lippincott Williams & Wilkins, Philadelphia.
  • Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F. and Cole G. (1996) Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274, 99102.
  • Im J. Y., Kim D., Paik S. G. and Han P. L. (2006) Cyclooxygenase-2-dependent neuronal death proceeds via superoxide anion generation. Free Radic. Biol. Med. 41, 960972.
  • Jankowsky J. L., Xu G., Fromholt D., Gonzales V. and Borchelt D. R. (2003) Environmental enrichment exacerbates amyloid plaque formation in a transgenic mouse model of Alzheimer disease. J. Neuropathol. Exp. Neurol. 62, 12201227.
  • Jeong Y. H., Park C. H., Yoo J., Shin K. Y., Ahn S. M., Kim H. S., Lee S. H., Emson P. C. and Suh Y. H. (2006) Chronic stress accelerates learning and memory impairments and increases amyloid deposition in APPV717I-CT100 transgenic mice, an Alzheimer’s disease model. FASEB J. 20, 729731.
  • Kang J. E., Cirrito J. R., Dong H., Csernansky J. G. and Holtzman D. M. (2007) Acute stress increases interstitial fluid amyloid-β via corticotropin-releasing factor and neuronal activity. Proc. Natl Acad. Sci. USA 104, 1067310678.
  • Kawarabayashi T., Younkin L. H., Saido T. C., Shoji M., Ashe K. H. and Younkin S. G. (2001) Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer’s disease. J. Neurosci. 21, 372381.
  • Kim K. S. and Han P. L. (2006) Optimization of chronic stress paradigms using anxiety- and depression-like behavioral parameters. J. Neurosci. Res. 83, 497507.
  • De Kloet E. R., Joëls M. and Holsboer F. (2005) Stress and the brain: from adaptation to disease. Nat. Rev. Neurosci. 6, 463475.
  • Koolhaas J. M., De Boer S. F., De Rutter A. J., Meerlo P. and Sgoifo A. (1997) Social stress in rats and mice. Acta Physiol. Scand. Suppl. 640, 6972.
  • Lee M. S. and Tsai L. H. (2003) Cdk5: one of the links between senile plaques and neurofibrillary tangles? J. Alzheimers Dis. 5, 127137.
  • Lee K. W., Im J. Y., Song J. S. et al. (2006) Progressive neuronal loss and behavioral impairments of transgenic C57BL/6 inbred mice expressing the carboxy terminus of amyloid precursor protein. Neurobiol. Dis. 22, 1024.
  • LePage R. N., Fosang A. J., Fuller S. J., Murphy G., Evin G., Beyreuther K., Masters C. L. and Small D. H. (1995) Gelatinase A possesses a β-secretase-like activity in cleaving the amyloid protein precursor of Alzheimer’s disease. FEBS Lett. 377, 267270.
  • Levine R. L., Garland D., Oliver C. N., Amici A., Climent I., Lenz A. G., Ahn B. W., Shaltiel S. and Stadtman E. R. (1990) Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 186, 464478.
  • Liang X., Wang Q., Hand T., Wu L., Breyer R. M., Montine T. J. and Andreasson K. (2005) Deletion of the prostaglandin E2 EP2 receptor reduces oxidative damage and amyloid burden in a model of Alzheimer’s disease. J. Neurosci. 25, 1018010187.
  • Lim G. P., Chu T., Yang F., Beech W., Frautschy S. A. and Cole G. M. (2001) The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J. Neurosci. 21, 83708377.
  • Lucassen P. J., Heine V. M., Muller M. B., Van der Beek E. M., Wiegant V. M., De Kloet E. R., Joels M., Fuchs E., Swaab D. F. and Czeh B. (2006) Stress, depression and hippocampal apoptosis. CNS Neurol. Disord. Drug Targets 5, 531546.
  • Magarinos A. M., McEwen B. S., Flugge G. and Fuchs E. (1996) Chronic psychosocial stress causes apical dendritic atrophy of hippocampal CA3 pyramidal neurons in subordinate tree shrews. J. Neurosci. 16, 35343540.
  • McEwen B. S. and Stellar E. (1993) Stress and the individual. Mechanisms leading to disease. Arch. Intern. Med. 153, 20932101.
  • Miners J. S., Baig S., Palmer J., Palmer L. E., Kehoe P. G. and Love S. (2008) Abeta-degrading enzymes in Alzheimer’s disease. Brain Pathol. 18, 240252.
  • Molchan S. E., Hill J. L., Mellow A. M., Lawlor B. A., Martinez R. and Sunderland T. (1990) The dexamethasone suppression test in Alzheimer’s disease and major depression: relationship to dementia severity, depression, and CSF monoamines. Int. Psychogeriatr. 2, 99122.
  • Okawa Y., Ishiguro K. and Fujita S. C. (2003) Stress-induced hyperphosphorylation of tau in the mouse brain. FEBS Lett. 535, 183189.
  • Ono K., Hamaguchi T., Naiki H. and Yamada M. (2006) Anti-amyloidogenic effects of antioxidants: implications for the prevention and therapeutics of Alzheimer’s disease. Biochim. Biophys. Acta 1762, 575586.
  • Plattner F., Angelo M. and Giese K. P. (2006) The roles of cyclin-dependent kinase 5 and glycogen synthase kinase 3 in tau hyperphosphorylation. J. Biol. Chem. 281, 2545725465.
  • Pomara N., Greenberg W. M., Branford M. D. and Doraiswamy P. M. (2003) Therapeutic implications of HPA axis abnormalities in Alzheimer’s disease: review and update. Psychopharmacol. Bull. 37, 120134.
  • Pratico D. (2005) Causes and consequences of oxidative stress in neurodegenerative diseases, in Genotype-Proteotype-Phenotype Relationships in Neurodegenerative Diseases (CummingsJ., Poncet M. and Christen Y., eds), pp. 3744. Springer-Verlag Press, Berlin.
  • Prince M. (1998) Is chronic low-level lead exposure in early life an etiologic factor in Alzheimer’s disease? Epidemiology 9, 618621.
  • Rogers J., Webster S., Lih-Fen L., Brachova L., Civin W. H., Emmerling M., Brenda S., Walker D. and McGeer P. (1996) Inflammation and Alzheimer’s disease pathogenesis. Neurobiol. Aging 17, 681686.
  • Roher A. E., Kasunic T. C., Woods A. S., Cotter R. J., Ball M. J. and Fridman R. (1994) Proteolysis of A beta peptide from Alzheimer disease brain by gelatinase A. Biochem. Biophys. Res. Commun. 205, 17551761.
  • Sauro M. D., Jorgensen R. S. and Pedlow C. T. (2003) Stress, glucocorticoids, and memory: a meta-analytic review. Stress 6, 235245.
  • Selkoe D. J. and Schenk D. (2003) Alzheimer’s disease: molecular understanding predicts amyloid-based therapeutics. Annu. Rev. Pharmacol. Toxicol. 43, 545584.
  • Suh Y. H. and Checler F. (2002) Amyloid precursor protein, presenilins, and alpha-synuclein: molecular pathogenesis and pharmacological applications in Alzheimer’s disease. Pharmacol. Rev. 54, 469525.
  • Sung S., Yao Y., Uryu K., Yang H., Lee V. M., Trojanowski J. Q. and Pratico D. (2004) Early vitamin E supplementation in young but not aged mice reduces Abeta levels and amyloid deposition in a transgenic model of Alzheimer’s disease. FASEB J. 18, 323325.
  • Tanzi R. E., Moir R. D. and Wagner S. L. (2004) Clearance of Alzheimer’s Abeta peptide: the many roads to perdition. Neuron 43, 605608.
  • Terry R. D., Masliah E. and Hansen L. A. (1999) Noncognitive symptoms of Alzheimer Disease, in Alzheimer Disease, 2nd edn (TerryR. D., Katzman R., Bick K. L. and Sisodia S. S., eds), pp. 187206. Lippincott Williams & Wilkins, Philadelphia.
  • Wilson R. S., Barnes L. L., Bennett D. A., Li Y., Bienias J. L., Mendes de Leon C. F. and Evans D. A. (2005) Proneness to psychological distress and risk of Alzheimer disease in a biracial community. Neurology 64, 380382.
  • Yin K. J., Cirrito J. R., Yan P. et al. (2006) Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-beta peptide catabolism. J. Neurosci. 26, 1093910948.
  • Zhu X., Su B., Wang X., Smith M. A. and Perry G. (2007) Causes of oxidative stress in Alzheimer disease. Cell. Mol. Life Sci. 64, 22022210.